For a patient with severe obstructive sleep apnea (AHI 38.6, 214 obstructive events, nadir SaO2 65%) who is reluctant to use positive airway pressure therapy, what alternative management strategies should be pursued, considering her neuropathic pain, nocturnal leg cramps, and dry mouth?

Management of Severe OSA in CPAP-Reluctant Patient

For this patient with severe OSA (AHI 38.6, nadir O2 65%), you should pursue a custom-made mandibular advancement device (MAD) as the primary alternative to CPAP, while simultaneously addressing her neuropathic pain and nocturnal leg cramps that are significantly contributing to her sleep disruption. 1, 2

Immediate Action Plan

1. Address CPAP Reluctance Through Education and Trial

Before abandoning CPAP entirely, implement a structured approach to overcome reluctance:

• Directly address her dry mouth concern - this is actually an OSA symptom that CPAP will likely improve, not worsen. Her severe dry mouth (mouth "stuck together") suggests significant mouth breathing during apneic events 3
• Explain that her current dry mouth is from untreated OSA, and proper CPAP with humidification will reduce this symptom
• Offer a short supervised trial (1 week) with heated humidification, emphasizing that her severe hypoxemia (65% O2 saturation) poses significant cardiovascular risk 3
• Use telemedicine/remote monitoring for early troubleshooting to improve adherence 3, 4

2. If CPAP Truly Fails: Mandibular Advancement Device

MAD is your best evidence-based alternative for severe OSA when CPAP fails 1, 2:

• Custom-made, dual-block, titrable MAD specifically (not over-the-counter devices) 2
• European guidelines show MAD has equal patient-related outcomes compared to CPAP, though AHI reduction is less 1
• Portuguese consensus specifically endorses MAD for severe OSA patients who refuse or cannot tolerate CPAP 2
• Requires dental evaluation first to rule out contraindications: severe periodontal disease, severe TMD, inadequate dentition 2

Important caveat: With her AHI of 38.6 and nadir O2 of 65%, MAD will likely not normalize her AHI as effectively as CPAP, but adherence to MAD typically exceeds CPAP adherence, potentially resulting in better overall treatment effect 2

3. Address Contributing Sleep Disruptors

Her neuropathy and leg cramps are major sleep fragmenters that will undermine any OSA therapy:

Neuropathic pain management:

• Her gabapentin is inadequate (she reports "pinching sensation no longer controlled")
• Consider increasing gabapentin dose or switching to pregabalin
• Alternative: duloxetine for neuropathic pain
• The sensitivity to touch (allodynia) and nocturnal worsening requires aggressive management

Nocturnal leg cramps:

• Magnesium supplementation (300-400mg before bed)
• Ensure adequate hydration
• Rule out metabolic causes (electrolytes, thyroid, vitamin D)
• Consider stretching protocol before bed

Nocturia:

• Multiple nocturnal awakenings to urinate will fragment sleep regardless of OSA treatment
• Evaluate for fluid intake timing, medications, diabetes control
• Consider sleep apnea itself as cause (will improve with treatment)

Alternative/Adjunctive Options

If MAD Also Fails or Is Contraindicated:

Hypoglossal nerve stimulation (HNS) 1, 5:

• Requires specific criteria: BMI <32 kg/m² (she's 153 lbs, need height), no complete concentric collapse on drug-induced sleep endoscopy
• Second-line therapy with good evidence for CPAP failures
• Her current weight (153 lbs) suggests she may be a candidate

Positional therapy 1:

• Only if her OSA is position-dependent (not documented in your HST report)
• Not appropriate as sole therapy for severe OSA

Oropharyngeal myofunctional therapy 3:

• Can be used as adjunct to any primary therapy
• May improve outcomes by 20-30% when combined with other treatments

What NOT to Do

• Do not use pharmacotherapy as primary treatment - No medications are approved for OSA treatment itself. Solriamfetol or modafinil only address residual sleepiness after adequate OSA treatment 3
• Do not recommend surgery as first alternative - Upper airway surgery should only be considered after MAD failure in severe OSA 1, 3
• Do not ignore the severity - Her nadir O2 of 65% represents severe intermittent hypoxemia with significant cardiovascular risk. Document your counseling about risks of untreated severe OSA

Follow-Up Protocol

If she proceeds with MAD 3, 4:

• Follow-up at 1 week, 1 month, 3 months
• Repeat sleep study at 3 months to assess efficacy
• Monitor for side effects: temporomandibular pain, tooth movement, excessive salivation
• If AHI remains >15-20 with persistent symptoms, consider combination therapy or escalation to HNS

Document extensively that you recommended CPAP as first-line therapy given her severe OSA with significant hypoxemia, explained cardiovascular risks of untreated disease, and that alternative therapies were pursued due to patient preference after informed discussion 1, 3.